Lambdas commitment to excellence has garnered significant recognition, including the Best Indian CRO award from Frost & Sullivan (USA) and the Great Indian Workplace title from UBS Transformance
The Core Difference in Trial Design: The SURPASS trials established tirzepatide's safety and glycemic efficacy in patients with type 2 diabetes, where weight loss was tracked as a secondary benefit
He is currently taking ibuprofen as needed, and metformin (850 mg qd) after being diagnosed with type 2 diabetes 10 years ago
Weight regain after discontinuation occurs if caloric intake increases back to pre-diet levels, which is a dietary adherence issue, not a metabolic rebound from stopping the injections
Abildgaard J, Ploug T, Pedersen AT, Eiken P, Pedersen BK, Holst JJ, et al
Young, J